Despite China’s falling birth rates and unfriendly political and business relationship with Australia, 2 major formula milk producers in Australia have reasserted their commitment to the China market.
Bubs Founder Kristy Carr has confimed this, so as the newly appointed Chief Executive of a2 milk, David Bortolussi saying ‘China drives nearly half of our sales and its way too big to ignore’.
Both companies saw China as a massive growth opportunity despite the falling birthrates. According to a recent report by a2 milk, “Chinese women are delaying pregnancies to get COVID-19 vaccinations.”
Bubs recorded an impressive 26% growth in direct sales of Bubs’ goat milk formula in China over the past 12 months despite the challenging pandemic which resulted in higher cost of logistics and transport. Even this failed to reverse its financial loss moving deeper into the negative territory from A$7.8 million (US$5.74 million) in 2020 to A$75 million (US$55.2 million) in 2021 financial year. The sharp contraction in ‘daigou’ sales and the prolonged wait to get regulatory approval from China’s State Administration for Market Registration are reasons attributed to the poor performance.
a2 milk, on the other hand said that “China is both our biggest risk and our biggest opportunity”. a2 milk also saw its revenue fell 30.3% to NZ$1.21 billion (US$1.16 billion) and its net profit plunged by 79.1% mainly attributed to a 66.4% drop in earnings from China and other Asian markets. The pandemic has seen a sharp reduction in ‘daigou’ resellers which contributed a big part to a2 sales. Domestic formula milk producers in China have taken this opportunity to fill up the gaps and creating more competition in this market.
a2 milk will focus on building its mother and baby store channel as well as its online capabilities in the China market to offset the disruption in the ‘daigou’ channel.